Hauv kev txhim kho tsis tu ncua ntawm kev tshawb fawb tshuaj, qee qhov sib xyaw ua ke sib cais rau lawv lub peev xwm los hloov kho cov txheej txheem kho.Ethyl 4-piperidone-3-carboxylate hydrochlorideyog ib qho kev sib xyaw ua ke uas tsis ntev los no tau txais kev saib xyuas ntau. Qhov nruab nrab hloov tau yooj yim no tau pom tias muaj kev lav phib xaub hauv ntau qhov chaw ntawm kev txhim kho tshuaj, muab lub zog rau kev kho mob ntawm ob peb yam mob. Cia peb tshawb xyuas qhov sib xyaw ua ke uas muaj peev xwm kho tau thiab seb nws yuav cuam tshuam li cas rau kev kho mob yav tom ntej.
Peb muab ETHYL 4-PIPERIDONE-3-CARBOXYLATE HYDROCHLORIDE, thov xa mus rau lub vev xaib hauv qab no kom paub meej cov lus qhia tshwj xeeb thiab cov khoom lag luam.
Khoom siv:https://www.bloomtechz.com/synthetic-chemical/organic-intermediates/ethyl-4-piperidone-3-carboxylate.html
Kev nkag siab txog cov qauv thiab cov khoom ntawm Ethyl 4-Piperidone-3-Carboxylate Hydrochloride
Ethyl 4-piperidone-3-carboxylate hydrochloride Cov qauv thiab cov yam ntxwv
Lub hydrochloride ntsev daim ntawv ntawm ethyl 4-piperidone-3-carboxylate ho txhim kho nws cov stability thiab solubility, ob qho tib si tseem ceeb heev rau kev siv tshuaj. Cov cuab yeej txhim kho no ua rau nws muaj peev xwm ua tau ntau yam hauv cov txheej txheem kev tsim tshuaj, ua rau cov kws tshawb fawb los tshawb xyuas nws cov peev xwm thoob plaws ntau thaj chaw kho mob. Los ntawm kev siv cov yam ntxwv no, cov kws tshawb fawb tuaj yeem tshawb nrhiav cov qauv tshiab thiab cov ntawv thov zoo dua, thaum kawg pab txhawb rau kev tshawb pom cov kev kho mob zoo rau ntau yam mob. Qhov kev hloov pauv no ua rau ethyl 4-piperidone-3-carboxylate hydrochloride ua ib qho tseem ceeb hauv thaj chaw tshuaj.
Ethyl 4-piperidone-3-carboxylate hydrochloride Cov qauv thiab cov yam ntxwv
Nkag siab txog ethyl 4-piperidone-3-carboxylate hydrochloride cov qauv tshuaj thiab cov khoom yog qhov tseem ceeb ua ntej txiav txim siab txog nws txoj kev kho mob. Cov tshuaj no muaj ib qho chaw nrog tsev neeg piperidone, piav qhia los ntawm ib tug rau-tus tswv cuab heterocyclic nplhaib uas muaj nitrogen molecule. Qhov no molecule lub cim reactivity yog vim nws cov carbonyl muaj nuj nqi thiab ethyl ester pab pawg neeg, ua rau nws ib tug pab tau lub tsev thaiv nyob rau hauv cov organic synthesis.
Kev cog lus kev siv tshuaj kho mob hauv Neurological Disorders
Tiag tiag tsom rau cov teeb meem neurological nyuaj
Muaj peev xwm thov ntawmethyl 4-piperidone-3-carboxylate hydrochloridenyob rau hauv kev kho mob ntawm neurological ntshawv siab yog ib qho ntawm feem kev vam meej cheeb tsam ntawm kev tshawb fawb. Cov qauv ntawm cov khoom sib txuas qhia tias nws tuaj yeem cuam tshuam nrog lub paj hlwb tshwj xeeb neurotransmitter, qhib qhov rooj los tsim kho tshiab rau kev mob vwm, Alzheimer's, thiab Parkinson's kab mob. Qhov kev sib koom tes no tuaj yeem ua rau muaj kev tshwm sim ntawm cov tshuaj tshiab uas tsom ntsoov rau cov xwm txheej ntawm lub paj hlwb, txhim kho cov txiaj ntsig ntawm tus neeg mob thiab ua haujlwm ntawm tus kheej txaus siab.
Muaj cov khoom siv neuroprotectiv
Cov subordinates ntawm ethyl 4-piperidone-3-carboxylate hydrochloride tuaj yeem muaj cov khoom tiv thaiv neuroprotective, raws li kev sim ntxiv tau pom. Los ntawm kev txo qis oxidative kev nyuaj siab thiab o hauv lub hlwb, cov tebchaw no tuaj yeem ua rau qeeb ntawm cov kab mob neurodegenerative. Cov kev tshawb pom tseem ceeb tau txhawb nqa thiab xav tau kev tshuaj xyuas ntxiv, txawm hais tias txoj kev tshawb nrhiav tseem nyob rau theem ntxov tshaj plaws.
Muaj peev xwm hloov kho lub hlwb receptor systems
Tsis tas li ntawd, qhov sib xyaw ua ke lub peev xwm los hloov kho lub hlwb receptor tshwj xeeb ua rau nws muaj kev vam meej tus neeg sib tw rau kev txhim kho cov tshuaj anticonvulsant tshiab. Kev qaug dab peg cuam tshuam rau ntau tus neeg thoob plaws ntiaj teb, thiab muaj kev xav tau txuas ntxiv rau cov tshuaj siv tau thiab zoo dua. Qhov khoob no tuaj yeem sau los ntawm ethyl 4-piperidone-3-carboxylate hydrochloride thiab nws cov derivatives, muab cov neeg mob uas tsis teb zoo rau cov tshuaj tiv thaiv kab mob tam sim no nrog kev cia siab.
Tshawb nrhiav cov ntawv thov muaj peev xwm hauv Kev Tswj Kev Mob thiab Kev Kho Mob
Ethyl 4-piperidone-3-carboxylate hydrochlorideTsis tas li ntawd qhia tau hais tias muaj kev lav phib xaub rau kev kho tus cwj pwm thiab kev txom nyem. Nws cov qauv qhia tias nws yuav cuam tshuam nrog opioid receptors, uas yog qhov tseem ceeb rau kev tswj xyuas qhov mob thiab kev coj cwj pwm zoo li cas. Qhov kev sib koom tes no tuaj yeem qhib txoj hauv kev tshiab rau kev tsim cov kev kho mob taw qhia rau kev saib xyuas kev tsim txom thiab ua rau muaj teeb meem siv tshuaj. Cov kws tshuaj ntsuam xyuas tab tom tshawb nrhiav lub peev xwm los tsim cov tshuaj tua kab mob tshiab tau txais los ntawm ethyl 4-piperidone-3-carboxylate hydrochloride, npaj siab los muab kev pabcuam muaj zog nrog kev tsis xis nyob nrog cov teebmeem tsawg dua li cov tshuaj noj tshuaj. Cov kev nce qib no tuaj yeem ua rau muaj kev cuam tshuam rau qhov kev pheej hmoo ntawm kev siv tshuaj yeeb tsis tu ncua, muab kev xaiv nyab xeeb dua rau kev saib xyuas kev mob nkeeg tas li thiab txo qis kev twv txiaj ntawm kev cia siab cuam tshuam nrog cov tshuaj yeeb tshuaj zoo tib yam.
Qhov sib xyaw ua ke yuav muaj kev sib txuas lus nrog narcotic receptors ua rau nws muaj kev sib cav sib ceg rau kev tsim cov tshuaj noj tshiab. Cov teeb meem siv tshuaj, tshwj xeeb tshaj yog opiate impulse, tseem yog ib qho kev sib tw hauv kev vam meej. Los ntawm kev txo qis kev ntshaw thiab txo cov tsos mob tshem tawm, ethyl 4-piperidone-3- cov tshuaj tau los ntawm carboxylate hydrochloride tuaj yeem pab tib neeg hauv lawv txoj kev rov qab los. Txoj hauv kev tshiab no tuaj yeem tau txais txiaj ntsig zoo rau cov tswv yim kho mob thiab kho cov txiaj ntsig tag nrho.
Ethyl 4-piperidone-3-carboxylate hydrochloride's adaptability ncav cuag cov hom phiaj no yav dhau los. Nws muaj peev xwm nyob rau hauv lwm qhov chaw kho mob, xws li cov kab mob plawv, cov teeb meem metabolic, thiab, xav tsis thoob, hom kev loj hlob ntawm malignant, yog cov kev tshawb fawb tsis tu ncua. Kev ceev ib nrab ntawm kev sib xyaw ntuj yog siv los ua lub pob zeb venturing rau kev txhim kho ntau yam bioactive mixs, txhua tus muaj peev xwm pab tau.
Thaum lub peev xwm ntawm ethyl 4-piperidone-3-carboxylate hydrochloride hauv kev nce qib ntawm cov tshuaj muaj zog, nws txhais tau hais tias ntau heev uas yuav tsum nco ntsoov tias me ntsis ntawm qhov kev tshawb fawb no tseem nyob rau theem preclinical. Txoj hauv kev los ntawm kev cog lus cog lus mus rau cov tshuaj uas tau pom zoo yog ntev thiab nyuaj, thiab nws yuav tsum muaj kev soj ntsuam kev nyab xeeb thiab kev ua tau zoo. Qhov sib xyaw no, ntawm qhov tod tes, yog ib qho khoom muaj nqis hauv kev lag luam kws tshuaj nrhiav kev kho tshiab thiab txhim kho vim nws muaj peev xwm siv ntau yam.
Raws li kev tshawb fawb txuas ntxiv, peb yuav pomethyl 4-piperidone-3-carboxylate hydrochlorideua lub luag haujlwm tseem ceeb hauv kev tsim cov tshuaj tiam tom ntej. Nws cov khoom siv tshuaj lom neeg tshwj xeeb thiab ntau yam ua rau nws muaj kev txaus siab rau cov kws tshawb fawb thiab cov tuam txhab tshuaj ib yam nkaus. Txawm hais tias nws nyob hauv thaj tsam ntawm neurology, kev tswj xyuas qhov mob, lossis lwm qhov chaw kho mob, cov organic intermediate tuav cov lus cog tseg ntawm kev pab txhawb rau kev nce qib hauv kev kho mob. Kev tshawb nrhiav ntawm ethyl 4-piperidone-3-carboxylate hydrochloride txoj kev kho mob muaj peev xwm qhia txog qhov tseem ceeb ntawm kev tshawb fawb txuas ntxiv thiab kev txhim kho hauv cov organic chemistry thiab kev tshawb fawb tshuaj. Raws li peb nthuav tawm ntau ntxiv txog qhov sib xyaw no thiab nws cov txiaj ntsig, peb txav mus los ze rau cov kev kho mob uas tuaj yeem txhim kho lub neej ntawm ntau lab tus tib neeg thoob ntiaj teb.
Xaus
Hauv kev xaus, ethyl 4-piperidone-3-carboxylate hydrochloride sawv cev rau thaj tsam ntawm kev tsim tshuaj. Nws cov ntawv thov muaj peev xwm nthuav dav ntau thaj chaw kho mob, los ntawm cov kab mob neurological mus rau kev tswj qhov mob thiab dhau mus. Txawm hais tias muaj ntau txoj haujlwm tseem yuav ua tiav, cov lus cog tseg los ntawm qhov sib xyaw no ua pov thawj rau qhov tseem ceeb ntawm kev tshawb fawb tshuaj lom neeg hauv kev kho mob kev tshawb fawb. Raws li peb saib mus rau yav tom ntej,ethyl 4-piperidone-3-carboxylate hydrochloridetej zaum yuav zoo nyob rau hauv pem hauv ntej ntawm txoj kev kho tshiab, muab kev cia siab rau kev txhim kho kev noj qab haus huv cov txiaj ntsig thoob plaws ntau yam kev kho mob.
Cov ntaub ntawv
1. Patil, ST, et al. (2018). "Piperidone derivatives: Synthesis thiab pharmacological kev siv." European Journal of Medicinal Chemistry, 155, 728-757.
2. Zhang, L., et al. (2020). "Kev nce qib tsis ntev los no hauv cov tshuaj chemistry ntawm piperidone derivatives." Phau ntawv Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 1391-1407.
3. Johnson, RE, et al. (2019). "Nov tshiab txoj hauv kev rau kev tswj qhov mob: tsom mus rau piperidone-based compounds." Kev Tshawb Fawb Kev Mob thiab Kev Tswj, 2019, 1-12.
4. Chen, Y., et al. (2021). "Piperidone derivatives raws li muaj peev xwm neuroprotective agents: Kev tshuaj xyuas." CNS & Neurological Disorders - Lub Hom Phiaj Tshuaj, 20(3), 213-229.
5. Smith, AB, et al. (2017). "Synthesis thiab lom tshuaj ntsuam xyuas ntawm cov tshiab piperidone derivatives li anticonvulsant agents." Bioorganic & Medicinal Chemistry Letters, 27(15), 3305-3310.